Another promising combination therapy involving ADAR1 is the treatment of cancer cells with epigenetic therapies, such as the DNMTi 5-aza-2′-deoxycytidine (also known as 5-AZA-CdR or decitabine). The gene discussed is ADAR; the disease is cancer.